Skip to content
value.today

Fountain Life, LLC

🇺🇸 Orlando, Florida, USAHealth CareFounded 2023
Total raised
$15 M
1 round on record
Latest round
$15 M
Dec 2023
First round on record
Dec 2023
Today
Private
No later event on record

Funding rounds

1 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Fountain Life, LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2023$15 MNo. 1$10 to $50 million

Fountain Life, LLC: Raise no. 1, Dec 2023

Investors in this round

15 investors had bought by the notice of Feb 6, 2024: 15 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M (amount offered: indefinite)
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • William K. Kapp, III, MD · Executive Officer, Director
  • Anthony H. Robins · Director
  • Dr. B.K. Tobin Modi · Director
  • J. Tobin Geatz · Director
  • Peter H. Diamandis, MD · Director
  • Sam Tobin Weigold · Director
  • Shawn H. Buchheit · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey J. Norton, Corporate Secretary. Source: SEC Form D, newest notice filed Feb 6, 2024. Read the notice at the SEC.

equitySEC
Nov 2023$87 MIssued in a merger or acquisition$50 to $250 million

Fountain Life, LLC: Private sale, Nov 2023

Investors in this round

61 investors had bought by the notice of Mar 11, 2025: 61 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$87 M of $87 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Anthony H. Robbins · Director
  • Dr. B.K. Tobin Modi · Director
  • J. Tobin Geatz · Director
  • Martin Tobin Weigold · Director
  • Peter H. Diamandis, MD · Director
  • Robert Tobin Hariri, MD · Director
  • Sam Tobin Evans · Director
  • Shawn H. Buchheit · Director
  • William K. Kapp, III, MD · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Exchange of units of Fountain Life, LLC for (i) outstanding units of Fountain Life Holdings, LLC, (ii) shares of Fountain Health Insurance, Inc. and (iii) units of Fountain LifeOmic, LLC”

Signed by Jeffrey J. Norton, Corporate Secretary. Source: SEC Form D and 2 amendments, newest notice filed Mar 11, 2025. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Fountain Life, LLC chose not to state its revenue in its newest notice of a funding round (Mar 2025).

    SEC Form D · Mar 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Feb 2024

That is all the official record says: Fountain Life, LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Fountain Life, LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 15 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Fountain Life, LLC
NameRoleNamed in
William K. Kapp, III, MDExecutive officerFeb 2024
Anthony H. RobbinsDirectorMar 2025
Dr. B.K. Tobin ModiDirectorMar 2025
J. Tobin GeatzDirectorMar 2025
Martin Tobin WeigoldDirectorMar 2025
Peter H. Diamandis, MDDirectorMar 2025
Robert Tobin Hariri, MDDirectorMar 2025
Sam Tobin EvansDirectorMar 2025
Shawn H. BuchheitDirectorMar 2025
William K. Kapp, III, MDDirectorMar 2025
Anthony H. RobinsDirectorFeb 2024
Sam Tobin WeigoldDirectorFeb 2024